118 related articles for article (PubMed ID: 12736670)
1. Computational biology: Biosensor design.
DeGrado WF
Nature; 2003 May; 423(6936):132-3. PubMed ID: 12736670
[No Abstract] [Full Text] [Related]
2. Computational design of receptor and sensor proteins with novel functions.
Looger LL; Dwyer MA; Smith JJ; Hellinga HW
Nature; 2003 May; 423(6936):185-90. PubMed ID: 12736688
[TBL] [Abstract][Full Text] [Related]
3. Biochemistry. De novo design of an enzyme.
Sterner R; Schmid FX
Science; 2004 Jun; 304(5679):1916-7. PubMed ID: 15218133
[No Abstract] [Full Text] [Related]
4. Periplasmic binding proteins: a versatile superfamily for protein engineering.
Dwyer MA; Hellinga HW
Curr Opin Struct Biol; 2004 Aug; 14(4):495-504. PubMed ID: 15313245
[TBL] [Abstract][Full Text] [Related]
5. Computational design of a biologically active enzyme.
Dwyer MA; Looger LL; Hellinga HW
Science; 2004 Jun; 304(5679):1967-71. PubMed ID: 15218149
[TBL] [Abstract][Full Text] [Related]
6. Design of a conformation-sensitive xenon-binding cavity in the ribose-binding protein.
Lowery TJ; Rubin SM; Ruiz EJ; Pines A; Wemmer DE
Angew Chem Int Ed Engl; 2004 Nov; 43(46):6320-2. PubMed ID: 15476190
[No Abstract] [Full Text] [Related]
7. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
8. Maltose-binding protein: a versatile platform for prototyping biosensing.
Medintz IL; Deschamps JR
Curr Opin Biotechnol; 2006 Feb; 17(1):17-27. PubMed ID: 16413768
[TBL] [Abstract][Full Text] [Related]
9. Construction of a reagentless glucose biosensor using molecular exciton luminescence.
Der BS; Dattelbaum JD
Anal Biochem; 2008 Apr; 375(1):132-40. PubMed ID: 18082614
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of a periplasmic substrate-binding protein in complex with calcium lactate.
Akiyama N; Takeda K; Miki K
J Mol Biol; 2009 Sep; 392(3):559-65. PubMed ID: 19631222
[TBL] [Abstract][Full Text] [Related]
12. New trends in bio/nanotechnology: stable proteins as advanced molecular tools for health and environment.
Staiano M; Baldassarre M; Esposito M; Apicella E; Vitale R; Aurilia V; D'Auria S
Environ Technol; 2010; 31(8-9):935-42. PubMed ID: 20662382
[TBL] [Abstract][Full Text] [Related]
13. Engineering of ligand specificity of periplasmic binding protein for glucose sensing.
Sakaguchi-Mikami A; Taneoka A; Yamoto R; Ferri S; Sode K
Biotechnol Lett; 2008 Aug; 30(8):1453-60. PubMed ID: 18414800
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling of hydration in drug design.
Mancera RL
Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
[TBL] [Abstract][Full Text] [Related]
15. Receptor flexibility in de novo ligand design and docking.
Alberts IL; Todorov NP; Dean PM
J Med Chem; 2005 Oct; 48(21):6585-96. PubMed ID: 16220975
[TBL] [Abstract][Full Text] [Related]
16. Direct observation of chaperone-induced changes in a protein folding pathway.
Bechtluft P; van Leeuwen RG; Tyreman M; Tomkiewicz D; Nouwen N; Tepper HL; Driessen AJ; Tans SJ
Science; 2007 Nov; 318(5855):1458-61. PubMed ID: 18048690
[TBL] [Abstract][Full Text] [Related]
17. 3D QSAR studies on a series of potent and high selective inhibitors for three kinases of RTK family.
Cao H; Zhang H; Zheng X; Gao D
J Mol Graph Model; 2007 Jul; 26(1):236-45. PubMed ID: 17293140
[TBL] [Abstract][Full Text] [Related]
18. Molecular optimization using computational multi-objective methods.
Nicolaou CA; Brown N; Pattichis CS
Curr Opin Drug Discov Devel; 2007 May; 10(3):316-24. PubMed ID: 17554858
[TBL] [Abstract][Full Text] [Related]
19. Analysis and optimization of structure-based virtual screening protocols. (3). New methods and old problems in scoring function design.
Smith R; Hubbard RE; Gschwend DA; Leach AR; Good AC
J Mol Graph Model; 2003 Sep; 22(1):41-53. PubMed ID: 12798390
[TBL] [Abstract][Full Text] [Related]
20. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
